Uranium associations with kidney outcomes vary by urine concentration adjustment method

Journal of Exposure Science and Environmental Epidemiology

Volumn 24, Issue 1, 2014, Pages 58-64

  Shelley, Rebecca ^a   Kim, Nam Soo ^b   Parsons, Patrick J ^c,d   Lee, Byung Kook ^b   Agnew, Jacqueline ^a   Jaar, Bernard G ^a,e,f   Steuerwald, Amy J ^c,d   Matanoski, Genevieve ^a   Fadrowski, Jeffrey ^e,f   Schwartz, Brian S ^a,e   Todd, Andrew C ^g   Simon, David ^h   Weaver, Virginia M ^a,e,f  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Soonchunhyang University   (South Korea)

^c WADSWORTH CENTER   (United States)

^d STATE UNIVERSITY OF NEW YORK   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^h Biostatistical Consulting   (United States)

Author keywords

Creatinine; Kidney function; Metals; Uranium

Indexed keywords

CREATININE; LEAD; URANIUM;

ADULT; ARTICLE; BLOOD; CHEMISTRY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MALE; METABOLISM; METALLURGY; MIDDLE AGED; OCCUPATIONAL EXPOSURE; TIBIA; URINE;

ADULT; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LEAD; MALE; METALLURGY; MIDDLE AGED; OCCUPATIONAL EXPOSURE; TIBIA; URANIUM;

EID: 84890794621     PISSN: 15590631     EISSN: 1559064X     Source Type: Journal    
DOI: 10.1038/jes.2013.18     Document Type: Article

References (49)

1. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU et al. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from kidney disease improving global outcomes. Kidney Int 2007; 72: 247-259.
2. Centers for Disease Control and Prevention. Fourth National Report on Human Exposure to Environmental Chemicals. Department of Health and Human Services: Atlanta, Georgia, 2009.
3. World Health Organization. Uranium in drinking-water: background document for development of WHO Guidelines for drinking-water quality 2004.
4. Kim YS, Park HS, Kim JY, Park SK, Cho BW, Sung IH et al. Health risk assessment for uranium in Korean groundwater. J Environ Radioact 2004; 77: 77-85.
5. Arzuaga X, Rieth SH, Bathija A, Cooper GS. Renal effects of exposure to natural and depleted uranium: a review of the epidemiologic and experimental data. J Toxicol Environ Health B Crit Rev 2010; 13: 527-545.
6. Vicente-Vicente L, Quiros Y, Perez-Barriocanal F, Lopez-Novoa JM, Lopez-Hernandez FJ, Morales AI. Nephrotoxicity of uranium: pathophysiological, diagnostic and therapeutic perspectives. Toxicol Sci 2010; 118: 324-347.
7. Agency for Toxic Substances and Disease Registry. Toxicological profile for Uranium (Draft for Public Comment). US Department of Health and Human Services, Public Health Service: Atlanta, Georgia, 2011.
8. Shelley R, Kim NS, Parsons P, Lee BK, Jaar B, Fadrowski J et al. Associations of multiple metals with kidney outcomes in lead workers. Occup Environ Med 2012; 69: 727-735.
9. Weaver VM, Kim NS, Jaar BG, Schwartz BS, Parsons PJ, Steuerwald AJ et al. Associations of low-level urine cadmium with kidney function in lead workers. Occup Environ Med 2011; 68: 250-256.
10. Weaver VM, Kim NS, Lee BK, Parsons PJ, Spector J, Fadrowski J et al. Differences in urine cadmium associations with kidney outcomes based on serum creatinine and cystatin C. Environ Res 2011; 111: 1236-1242.
11. Schwartz BS, Lee BK, Lee GS, Stewart WF, Lee SS, Hwang KY et al. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with neurobehavioral test scores in South Korean lead workers. Am J Epidemiol 2001; 153: 453-464.
12. Weaver VM, Lee BK, Ahn KD, Lee GS, Todd AC, Stewart WF et al. Associations of lead biomarkers with renal function in Korean lead workers. Occup Environ Med 2003; 60: 551-562.
13. Minnich MG, Miller DC, Parsons PJ. Determination of As, Cd, Pb and Hg in urine using inductively coupled plasma mass spectrometry with the direct injection high efficiency nebulizer. Spectrochimica Acta Part B: Atomic Spectroscopy 2008; 63: 389-395.
14. Thompson M, Ellison SLR, Wood R. Harmonized guidelines for single-laboratory validation of methods of analysis (IUPAC Technical Report). Pure Applied Chem 2002; 74: 835-855.
15. Fernandez FJ. Micromethod for lead determination in whole blood by atomic absorption, with use of the graphite furnace. Clin Chem 1975; 21: 558-561.
16. Todd AC. Contamination of in vivo bone-lead measurements. Phys Med Biol 2000; 45: 229-240.
17. Todd AC, Chettle DR. Calculating the uncertainty in lead concentration for in vivo bone lead X-ray fluorescence. Phys Med Biol 2003; 48: 2033-2039.
18. Todd AC, Parsons PJ, Carroll S, Geraghty C, Khan FA, Tang S et al. Measurements of lead in human tibiae. A comparison between K-shell x-ray fluorescence and electrothermal atomic absorption spectrometry. Phys Med Biol 2002; 47: 673-687.
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
20. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147.
21. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51: 395-406.
22. StataCorp. Stata Statistical Software: Release 11, 9th edn. StataCorp LP: College Station, TX, USA, 2009.
23. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. Urinary creatinine concentrations in the US population: implications for urinary biologic monitoring measurements. Environ Health Perspect 2005; 113: 192-200.
24. Chen X, Ender P, Mitchell M, Wells C. Regression with Stata 2003, Available from http://www.ats.ucla.edu/stat/stata/webbooks/reg/default.htm.
25. Weisberg S. Applied linear regression. John Wiley and Sons: New York, NY, USA, 1985.
26. Brugge D, de Lemos JL, Oldmixon B. Exposure pathways and health effects associated with chemical and radiological toxicity of natural uranium: a review. Rev Environ Health 2005; 20: 177-193.
27. Leggett RW, Harrison JD. Fractional absorption of ingested uranium in humans. Health Phys 1995; 68: 484-498.
28. Centers for Disease Control and Prevention. The Fourth National Report on Human Exposure to Environmental Chemicals. Updated Tables. Department of Health and Human Services: Atlanta, GA, USA, 2012.
29. Yapar K, Cavusoglu K, Oruc E, Yalcin E. Protective role of Ginkgo biloba against hepatotoxicity and nephrotoxicity in uranium-treated mice. J Med Food 2010; 13: 179-188.
30. Hooper FJ, Squibb KS, Siegel EL, McPhaul K, Keogh JP. Elevated urine uranium excretion by soldiers with retained uranium shrapnel. Health Phys 1999; 77: 512-519.
31. Kurttio P, Auvinen A, Salonen L, Saha H, Pekkanen J, Makelainen I et al. Renal effects of uranium in drinking water. Environ Health Perspect 2002; 110: 337-342.
32. Kurttio P, Harmoinen A, Saha H, Salonen L, Karpas Z, Komulainen H et al. Kidney toxicity of ingested uranium from drinking water. Am J Kidney Dis 2006; 47: 972-982.
33. McDiarmid MA, Keogh JP, Hooper FJ, McPhaul K, Squibb K, Kane R et al. Health effects of depleted uranium on exposed Gulf War veterans. Environ Res 2000; 82: 168-180.
34. McDiarmid MA, Engelhardt SM, Oliver M, Gucer P, Wilson PD, Kane R et al. Health surveillance of gulf war I veterans exposed to depleted uranium: updating the cohort. Health Phy 2007; 93: 60-73.
35. Pinney SM, Freyberg RW, Levine GE, Brannen DE, Mark LS, Nasuta JM et al. Health effects in community residents near a uranium plant at Fernald, Ohio, USA. Int J Occup Med Environ Health 2003; 16: 139-153.
36. Thun MJ, Baker DB, Steenland K, Smith AB, Halperin W, Berl T. Renal toxicity in uranium mill workers. Scand J Work Environ Health 1985; 11: 83-90.
37. McDiarmid MA, Engelhardt S, Oliver M, Gucer P, Wilson PD, Kane R et al. Health effects of depleted uranium on exposed Gulf War veterans: a 10-year follow-up. J Toxicol Environ Health A 2004; 67: 277-296.
38. McDiarmid MA, Engelhardt SM, Oliver M, Gucer P, Wilson PD, Kane R et al. Biological monitoring and surveillance results of Gulf War I veterans exposed to depleted uranium. Int Arch Occup Environ Health 2006; 79: 11-21.
39. McDiarmid MA, Engelhardt SM, Dorsey CD, Oliver M, Gucer P, Wilson PD et al. Surveillance results of depleted uranium-exposed Gulf War I veterans: sixteen years of follow-up. J Toxicol Environ Health A 2009; 72: 14-29.
40. McDiarmid MA, Squibb K, Engelhardt S, Oliver M, Gucer P, Wilson PD et al. Surveillance of depleted uranium exposed Gulf War veterans: health effects observed in an enlarged "friendly fire" cohort. J Occup Environ Med 2001; 43: 991-1000.
41. McDiarmid MA, Engelhardt SM, Dorsey CD, Oliver M, Gucer P, Gaitens JM et al. Longitudinal health surveillance in a cohort of Gulf War veterans 18 years after first exposure to depleted uranium. J Toxicol Environ Health A 2011; 74: 678-691.
42. Chaumont A, Nickmilder M, Dumont X, Lundh T, Skerfving S, Bernard A. Associations between proteins and heavy metals in urine at low environmental exposures: Evidence of reverse causality. Toxicol Lett 2012; 210: 345-352.
43. Urakami Y, Kimura N, Okuda M, Inui K. Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney. Pharm Res 2004; 21: 976-981.
44. Eisner C, Faulhaber-Walter R, Wang Y, Leelahavanichkul A, Yuen PS, Mizel D et al. Major contribution of tubular secretion to creatinine clearance in mice. Kidney Int 2010; 77: 519-526.
45. Ciarimboli G, Lancaster CS, Schlatter E, Franke RM, Sprowl JA, Pavenstadt H et al. Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients. Clin Cancer Res 2012; 18: 1101-1108.
46. Muller D, Houpert P, Cambar J, Henge-Napoli MH. Role of the sodium-dependent phosphate co-transporters and of the phosphate complexes of uranyl in the cytotoxicity of uranium in LLC-PK1 cells. Toxicol Appl Pharmacol 2006; 214: 166-177.
47. Ferraro PM, Costanzi S, Naticchia A, Sturniolo A, Gambaro G. Low level exposure to cadmium increases the risk of chronic kidney disease: analysis of the NHANES 1999-2006. BMC Public Health 2010; 10: 304.
48. You L, Zhu X, Shrubsole MJ, Fan H, Chen J, Dong J et al. Renal function, bisphenol A and alkylphenols: results from the National Health and Nutrition Examination Survey (NHANES 2003-2006). Environ Health Perspect 2011; 119: 527-533.
49. Akerstrom M, Lundh T, Barregard L, Sallsten G. Sampling of urinary cadmium: differences between 24-h urine and overnight spot urine sampling, and impact of adjustment for dilution. Int Arch Occup Environ Health 2012; 85: 189-196.